The State of Texas Attorney General Sues Acetaminophen Makers Concerning Autism Claims

The top legal official in Texas Ken Paxton is taking legal action against the producers of acetaminophen, claiming the corporations withheld safety concerns that the drug presented to children's cognitive development.

The court filing follows four weeks after Former President Trump promoted an unverified association between consuming acetaminophen - alternatively called acetaminophen - while pregnant and autism in young ones.

Paxton is taking legal action against J&J, which previously sold the drug, the sole analgesic approved for expectant mothers, and Kenvue, which presently makes it.

In a statement, he stated they "deceived the public by profiting off of pain and promoting medication without regard for the risks."

The company states there is no credible evidence connecting acetaminophen to autism.

"These companies lied for decades, intentionally threatening countless individuals to boost earnings," Paxton, a Republican, stated.

The manufacturer commented that it was "very worried by the perpetuation of misinformation on the reliability of paracetamol and the possible consequences that could have on the well-being of women and children in America."

On its website, Kenvue also said it had "regularly reviewed the relevant science and there is insufficient valid information that shows a verified association between taking acetaminophen and autism spectrum disorder."

Organizations acting on behalf of doctors and medical practitioners concur.

The American College of Obstetricians and Gynecologists has stated paracetamol - the primary component in Tylenol - is among limited choices for women during pregnancy to address discomfort and elevated temperature, which can pose major wellness concerns if not addressed.

"In over twenty years of research on the consumption of acetaminophen in pregnancy, zero credible investigations has successfully concluded that the consumption of paracetamol in any trimester of gestation leads to neurological conditions in young ones," the association stated.

The court filing references recent announcements from the Trump administration in claiming the medication is reportedly hazardous.

Recently, Trump raised alarms from health experts when he advised expectant mothers to "resist strongly" not to use Tylenol when unwell.

Federal regulators then published an announcement that medical professionals should contemplate reducing the usage of acetaminophen, while also stating that "a direct connection" between the drug and autism spectrum disorder in minors has remains unverified.

Health Secretary Robert F Kennedy Jr, who manages the Food and Drug Administration, had promised in spring to initiate "extensive scientific investigation" that would identify the source of autism in a matter of months.

But authorities advised that finding a single cause of autism - thought by researchers to be the outcome of a intricate combination of genetic and surrounding conditions - would be difficult.

Autism is a form of enduring cognitive variation and condition that influences how people perceive and relate to the surroundings, and is diagnosed using physician assessments.

In his court filing, the attorney general - aligned with the former president who is campaigning for the Senate - asserts Kenvue and Johnson & Johnson "deliberately disregarded and tried to quiet the science" around paracetamol and autism.

This legal action seeks to make the firms "destroy any commercial messaging" that asserts acetaminophen is safe for pregnant women.

This legal action echoes the concerns of a collection of parents of minors with autism spectrum disorder and ADHD who took legal action against the makers of acetaminophen in recently.

The court threw out the legal action, stating research from the parents' expert witnesses was lacking definitive proof.